Arterial Remodeling in Smokers
TCA
Response-to-injury in Patients Undergoing Transradial Coronary Angiography: Arterial Remodeling in Smokers
1 other identifier
observational
50
1 country
1
Brief Summary
Cigarette smoking is the most important modifiable cardiovascular risk factor leading to endothelial dysfunction and was suggested to impair arterial regeneration.The aim of the study was to investigate the effect of smoking on vascular response to transradial coronary angiography (TCA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 22, 2013
CompletedFirst Posted
Study publicly available on registry
May 24, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedJune 4, 2014
June 1, 2014
1.2 years
May 22, 2013
June 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
IMT hyperplasia
IMT is measured by high resolution ultrasound in the radial arteries.
change in radials IMT after 6-14 month after a TCA
Secondary Outcomes (1)
Endothelial function
change in flow mediated dilatation after 10-14 months
Other Outcomes (2)
cell migration
baseline
Regeneration
baseline
Study Arms (2)
Current Smoker underwent TCA
subjects who smokes daily
Former Smokers underwent TCA
subjects who do not smoke since 7 years
Interventions
Eligibility Criteria
all subjects who underwent an TCA (trans radial catheterisation)
You may qualify if:
- all subjects underwent a TCA
You may not qualify if:
- acute inflammation cardiac arrhythmia renal failure heart failure (NYHA II-IV) CRP \> 1 mg/dl malignant disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Division of Cardiology, Pulmonology and Vascular Medicine Duesseldorf,
Düsseldorf, North Rhine-Westphalia, 40225, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christian Heiss, MD
Division of Cardiology, Pulmonology and Vascular Medicine
- STUDY CHAIR
Malte Kelm, MD
Division of Cardiology, Pulmonology and Vascular Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Division of Cardiology, Pulmonary Diseases, Vascular Medicine
Study Record Dates
First Submitted
May 22, 2013
First Posted
May 24, 2013
Study Start
April 1, 2013
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
June 4, 2014
Record last verified: 2014-06